These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17434545)

  • 1. An angiotensin II receptor blocker increases sexual behavior in type 2 diabetic mice.
    Nomura M; Nishii H; Ozaki Y; Fujimoto N; Matsumoto T
    Physiol Behav; 2007 Jun; 91(2-3):223-8. PubMed ID: 17434545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
    Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of glucose intolerance by combination of pravastatin and olmesartan in type II diabetic KK-A(y) mice.
    Kanno H; Iwai M; Inaba S; Senba I; Nakaoka H; Sone H; Mogi M; Horiuchi M
    Hypertens Res; 2009 Aug; 32(8):706-11. PubMed ID: 19478815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
    Igarashi M; Hirata A; Nozaki H; Kadomoto-Antsuki Y; Tominaga M
    Diabetes Res Clin Pract; 2007 Mar; 75(3):267-77. PubMed ID: 16934905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension.
    Sakairi A; Ishida J; Honjo K; Inaba S; Nakamura S; Sugiyama F; Yagami K; Fukamizu A
    Hypertens Res; 2008 Dec; 31(12):2165-75. PubMed ID: 19139606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models.
    Tomono Y; Iwai M; Inaba S; Mogi M; Horiuchi M
    Am J Hypertens; 2008 Feb; 21(2):206-12. PubMed ID: 18188158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice.
    Lakshmanan AP; Thandavarayan RA; Watanabe K; Sari FR; Meilei H; Giridharan VV; Sukumaran V; Soetikno V; Arumugam S; Suzuki K; Kodama M
    Mol Cell Endocrinol; 2012 Jan; 348(1):104-11. PubMed ID: 21827824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
    Pugsley MK
    Proc West Pharmacol Soc; 2005; 48():35-8. PubMed ID: 16416656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute stress on sexual behavior in female rats: participation of the central angiotensinergic system.
    Cecconello AL; Raineki C; Sebben V; Lucion AB; Sanvitto GL
    Behav Brain Res; 2010 Mar; 207(2):429-33. PubMed ID: 19879304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production.
    Shimada K; Murayama T; Yokode M; Kita T; Fujita M; Kishimoto C
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):672-8. PubMed ID: 20399087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model.
    Ohtomo S; Ito M; Izuhara Y; Van Ypersele De Strihou C; Miyata T
    Nephrology (Carlton); 2008 Dec; 13(6):517-21. PubMed ID: 18363646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
    Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome.
    Takahashi S; Nakamura Y; Nishijima T; Sakurai S; Inoue H
    Respir Med; 2005 Sep; 99(9):1125-31. PubMed ID: 16085213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olmesartan induces renoprotective effects by stimulating angiotensin type 2 receptors and reducing oxidative stress in diabetic nephropathy.
    Jo F; Morimoto S; Nakahigashi M; Kusabe M; Someya K; Morita T; Jo H; Imada T; Kosaki A; Toyoda N; Nishikawa M; Iwasaka T
    Kidney Blood Press Res; 2011; 34(6):418-23. PubMed ID: 21709422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
    Kano S; Satoh K; Kaneta S; Ichihara K
    Pharmacology; 2008; 82(1):22-9. PubMed ID: 18434761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olmesartan ameliorates peripheral nerve dysfunction in Zucker diabetic fatty rats.
    Sugimoto K; Kojima K; Baba M; Yasujima M
    J Hypertens; 2011 Jul; 29(7):1337-46. PubMed ID: 21602711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats.
    Matsuyama N; Tsutsumi T; Kubota N; Nakajima T; Suzuki H; Takeyama Y
    Hypertens Res; 2009 Aug; 32(8):721-6. PubMed ID: 19590505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
    You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y
    J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.